We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.44B
AUM Growth
+$90.8M
Cap. Flow
-$56.4M
Cap. Flow %
-2.31%
Top 10 Hldgs %
17.91%
Holding
294
New
24
Increased
63
Reduced
122
Closed
61

Top Buys

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$21.1M
2
KMT icon
Kennametal
KMT
+$20.2M
3
CLF icon
Cleveland-Cliffs
CLF
+$16.1M
4
NEX
NexTier Oilfield Solutions Inc.
NEX
+$15.6M
5
MTUS icon
Metallus
MTUS
+$14M

Top Sells

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$23.7M
2
SCOR icon
Comscore
SCOR
+$20M
3
URBN icon
Urban Outfitters
URBN
+$15M
4
IBKC
IBERIABANK Corp
IBKC
+$14.3M
5
PENN icon
PENN Entertainment
PENN
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Industrials 19.84%
3 Consumer Discretionary 14.17%
4 Healthcare 13.8%
5 Financials 11.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCLR
76
DELISTED
Oclaro Inc.
OCLR
$13.1M 0.54%
+1,331,886
New +$12.5M
SLCA
77
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$12.7M 0.52%
265,393
+240,023
+946% +$12.8M
WTFC icon
78
Wintrust Financial
WTFC
$11.1B
$12.7M 0.52%
184,035
+13,025
+8% +$936K
AIMT
79
DELISTED
Aimmune Therapeutics
AIMT
$12.7M 0.52%
583,566
-189,429
-25% -$3.89M
PLAY icon
80
Dave & Buster's
PLAY
$354M
$12.7M 0.52%
207,509
-880
-0.4% -$50.1K
ALDR
81
DELISTED
Alder Biopharmaceuticals
ALDR
$12.5M 0.51%
601,832
-11,400
-2% -$252K
MXL icon
82
MaxLinear
MXL
$6.43B
$12.2M 0.5%
+433,535
New +$11.1M
OPB
83
DELISTED
Opus Bank Common Stock
OPB
$12.1M 0.5%
600,560
-162,242
-21% -$3.71M
COHR
84
DELISTED
Coherent Inc
COHR
$12M 0.49%
+58,436
New +$10.2M
NEX
85
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$12M 0.49%
+840,028
New +$15.6M
PTLA
86
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$11.4M 0.47%
291,993
-394,058
-57% -$12.6M
KATE
87
DELISTED
Kate Spade & Company
KATE
$11.1M 0.45%
475,701
-166,295
-26% -$3.48M
ATRC icon
88
AtriCure
ATRC
$1.77B
$11M 0.45%
576,517
-7,220
-1% -$126K
AEO icon
89
American Eagle Outfitters
AEO
$2.85B
$10.5M 0.43%
749,456
-272,970
-27% -$4.06M
XTLY
90
DELISTED
Xactly Corporation
XTLY
$10.5M 0.43%
880,099
+59,935
+7% +$712K
SAGE
91
DELISTED
Sage Therapeutics
SAGE
$10.3M 0.42%
+145,018
New +$8.49M
NEO icon
92
NeoGenomics
NEO
$1.9B
$10.1M 0.41%
1,274,860
+297,604
+30% +$2.42M
CCNE icon
93
CNB Financial Corp
CCNE
$1.02B
$9.79M 0.4%
409,902
-15,921
-4% -$395K
TOL icon
94
Toll Brothers
TOL
$14.1B
$9.63M 0.4%
266,598
+2,044
+0.8% +$68.2K
ELLI
95
DELISTED
Ellie Mae Inc
ELLI
$9.56M 0.39%
95,319
-16,502
-15% -$1.52M
AMRI
96
DELISTED
Albany Molecular Research Inc
AMRI
$9.4M 0.39%
669,705
-23,850
-3% -$391K
MTW icon
97
Manitowoc
MTW
$468M
$9.38M 0.39%
411,504
+387,982
+1,649% +$9.57M
IPHI
98
DELISTED
INPHI CORPORATION
IPHI
$9.31M 0.38%
190,722
+6,850
+4% +$320K
ADMS
99
DELISTED
Adamas Pharmaceuticals
ADMS
$9.08M 0.37%
518,685
+140
+0% +$2.39K
MGNX icon
100
MacroGenics
MGNX
$285M
$8.88M 0.36%
477,260
-5,575
-1% -$108K
2 3
4
5 6

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, Emerald Advisers held 294 positions worth $2.44B, up 3.9% from $2.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q1 2017 filing shows 24 new, 63 increased, 122 reduced and 61 closed positions. Its largest new stake was Primoris Services: 876,734 shares worth $20.4M. The largest sale was Ultragenyx Pharmaceutical, an estimated $23.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q1 2017 buy was Primoris Services: 876,734 shares worth $20.4M.
  • Emerald Advisers added most to Moelis & Co in Q1 2017, an estimated $13.3M increase.
  • Emerald Advisers's biggest Q1 2017 reduction was PENN Entertainment, cutting an estimated $13.7M.
  • Emerald Advisers fully exited Ultragenyx Pharmaceutical in Q1 2017, selling an estimated $23.7M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.44B portfolio in Q1 2017.
  • Emerald Advisers opened 24 new positions and closed 61 in Q1 2017.
  • Emerald Advisers's portfolio value rose 3.9% quarter-over-quarter to $2.44B.

Based on Emerald Advisers's 13F filing for Q1 2017, filed 28 Apr 2017.